Metformin Stada

Metformin, the active ingredient in Metformin Stada, is a Biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control.

GNH USA supplies Metformin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Stada is used within the antidiabetic drug class to manage disorders of glucose metabolism.

- Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. - Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity.

Metformin Stada may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Hypoglycaemia: when combined with other glucose‑lowering agents. - Vitamin B12 deficiency: long‑term use may reduce absorption.

Before initiating Metformin Stada, several safety considerations should be reviewed.

- Renal function assessment: ensure adequate glomerular filtration rate before use. - Hepatic status evaluation: avoid in patients with significant liver disease. - Lactic acidosis risk: monitor for symptoms in patients with hypoxia or heart failure. - Concomitant medication review: adjust dose when used with drugs that affect renal clearance. - Elderly dosing: consider lower starting dose and slower titration. - Store at ambient temperature: keep in the original container, protect from moisture.

Metformin Stada can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol excess: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment. - Diuretics: may reduce renal clearance of metformin. - Calcium channel blockers: potential additive effect on blood glucose. - Warfarin: may require INR monitoring.